HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo Palmieri Selected Research

irosustat

1/2018Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
11/2017IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.
9/2017IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
2/2011Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlo Palmieri Research Topics

Disease

59Breast Neoplasms (Breast Cancer)
08/2022 - 04/2004
32Neoplasms (Cancer)
02/2022 - 06/2004
12Neoplasm Metastasis (Metastasis)
08/2022 - 08/2005
4Brain Neoplasms (Brain Tumor)
01/2021 - 01/2015
2COVID-19
01/2022 - 01/2021
2Cardiotoxicity
04/2014 - 12/2008
2Infections
01/2012 - 02/2006
1Bone Diseases (Bone Disease)
08/2022
1Disease Progression
08/2022
1Microsatellite Instability
10/2021
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
12/2013
1Multiple Myeloma
12/2013
1Residual Neoplasm
02/2012
1Angiosarcoma of the breast
12/2008

Drug/Important Bio-Agent (IBA)

13Estrogen ReceptorsIBA
02/2022 - 04/2004
8Pharmaceutical PreparationsIBA
07/2019 - 11/2009
7Trastuzumab (Herceptin)FDA Link
06/2022 - 06/2008
7TamoxifenFDA LinkGeneric
11/2020 - 12/2008
6Biomarkers (Surrogate Marker)IBA
10/2021 - 11/2011
6Aromatase InhibitorsIBA
01/2018 - 04/2004
5DNA (Deoxyribonucleic Acid)IBA
11/2021 - 02/2012
4Steryl-Sulfatase (Steroid Sulfatase)IBA
01/2018 - 02/2011
4irosustatIBA
01/2018 - 02/2011
4AnthracyclinesIBA
04/2014 - 12/2008
4Proteins (Proteins, Gene)FDA Link
02/2013 - 08/2005
3Capecitabine (Xeloda)FDA Link
08/2022 - 11/2009
3ErbB Receptors (EGF Receptor)IBA
02/2022 - 06/2011
3Progesterone Receptors (Progesterone Receptor)IBA
09/2021 - 09/2009
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 12/2016
3Estrogen Receptor alphaIBA
01/2018 - 12/2007
3Lapatinib (GW572016)FDA Link
09/2017 - 07/2009
3Transcription Factors (Transcription Factor)IBA
02/2013 - 07/2009
3Choline (Choline Chloride)IBA
11/2011 - 09/2009
3Fulvestrant (Faslodex)FDA Link
11/2011 - 05/2009
2Radium-223IBA
08/2022 - 01/2020
2CarbonIBA
08/2022 - 01/2020
2human ERBB2 proteinIBA
06/2022 - 02/2022
2Peptides (Polypeptides)IBA
10/2021 - 06/2008
2Cell-Free Nucleic AcidsIBA
01/2021 - 02/2012
2eribulinFDA Link
01/2021 - 02/2014
2Hormones (Hormone)IBA
01/2020 - 06/2009
2Steroid Receptors (Steroid Receptor)IBA
12/2016 - 02/2010
2LigandsIBA
12/2016 - 06/2008
2ChromatinIBA
01/2016 - 01/2012
2liposomal doxorubicin (Doxil)FDA Link
04/2014 - 12/2008
2Taxoids (Taxanes)IBA
02/2014 - 10/2010
2Biological ProductsIBA
11/2011 - 07/2009
2taxaneIBA
10/2010 - 12/2008
1collagen type I trimeric cross-linked peptideIBA
08/2022
1RadiopharmaceuticalsIBA
08/2022
1Collagen Type I (Type I Collagen)IBA
08/2022
1Cyclin D1IBA
02/2022
11'-acetoxychavicol acetateIBA
02/2022
1pertuzumabIBA
01/2022
1C-Reactive ProteinIBA
01/2022
1AlbuminsIBA
01/2022
1APOBEC-1 DeaminaseIBA
10/2021
1atezolizumabIBA
10/2021
1Immune Checkpoint InhibitorsIBA
10/2021
1B7-H1 AntigenIBA
10/2021
1pembrolizumabIBA
10/2021
1Celecoxib (Celebrex)FDA Link
09/2021
1Circulating Tumor DNAIBA
01/2021
1DNA-Binding Proteins (DNA Binding Protein)IBA
11/2020
1MicroRNAs (MicroRNA)IBA
12/2019
1Glutathione (Reduced Glutathione)IBA
07/2019
1Silicon Dioxide (Silica)FDA LinkGeneric
07/2019
1Zinc OxideFDA Link
07/2019
1exemestane (Aromasin)FDA Link
05/2019
1Phenobarbital (Luminal)FDA Link
01/2018
1Serine (L-Serine)FDA Link
01/2016
1Carbon-11IBA
01/2015
1Angiogenesis InhibitorsIBA
02/2014
1halichondrin BIBA
02/2014
1Pamidronate (Aredia)FDA LinkGeneric
12/2013
1Clodronic Acid (Clodronate)IBA
12/2013
1Ibandronic Acid (Boniva)FDA Link
12/2013
1Zoledronic Acid (Zometa)FDA Link
12/2013
1Diphosphonates (Bisphosphonates)IBA
12/2013
1ThymidineIBA
06/2012
1Endo180IBA
04/2012
1CollagenIBA
04/2012
1Docetaxel (Taxotere)FDA Link
01/2012
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2012
1Epidermal Growth Factor (EGF)IBA
09/2009
1Messenger RNA (mRNA)IBA
07/2009
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2009
1Phosphotransferases (Kinase)IBA
07/2009
1ParaffinIBA
07/2009
1Small Interfering RNA (siRNA)IBA
07/2009
1Aromatase (CYP19)IBA
05/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2008

Therapy/Procedure

23Therapeutics
06/2022 - 04/2004
9Drug Therapy (Chemotherapy)
01/2022 - 03/2005
3Neoadjuvant Therapy
01/2022 - 03/2016
1Immunotherapy
01/2021
1Aftercare (After-Treatment)
11/2009
1Adjuvant Radiotherapy
12/2008
1Radiotherapy
12/2008